A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects
European Journal of Pharmaceutics and Biopharmaceutics · 2026
DOI: 10.1016/j.ejpb.2026.114988 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Zhiling Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Hauptthemen laut MEDLINE: Imipramine, Analgesics, Celecoxib. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Jiangsu Ocean University.
Abstract (Originalsprache)
Because the monotherapy of currently available pain killers often shows serious adverse effects or limited efficacy for treating neuropathic pain, multimodal analgesia has been highly recommended to gain improved antinociceptive effects and reduce dose-dependent side effects. Drug-drug co-amorphous systems emerge as a useful strategy for ameliorating the physicochemical properties of drug substances and achieving clinical benefits compared with individual components. New drug-drug co-amorphous products IMI-CEL at different ratios were prepared from imipramine hydrochloride (IMI) and a poorly water-soluble anti-inflammatory drug-celecoxib (CEL) by melt-quenching method, which were characterized by XRPD, DSC and IR. Co-amorphous product IMI-CEL (1:1) displayed notable improvement in the solubility (64.4 times) and dissolution rate (3.1 times) than crystalline CEL in pH 6.8 buffer, and IMI-CEL exhibited good physical stability under long-term storage conditions. Isobolographic analysis demonstrated that IMI-CEL (1:1) showed synergistic analgesic effects in paclitaxel-induced neuropathic pain in mice. Moreover, the oral bioavailability of 1:1 IMI-CEL was improved 1.396 times in rats when compared to the single drug. Above results suggested the potential of IMI-CEL to produce synergistic analgesic effects through developing drug-drug co-amorphous systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China.
- School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Electronic address: 2019000013@jou.edu.cn.
- School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China. Electronic address: zhuang_tao@jou.edu.cn.
Förderung
- Jiangsu Ocean University
Zitieren
APA
Chen, Z., Zhou, H., Song, J., Xu, B., Wang, C., He, F., Zhang, G., & Zhuang, T. (2026). A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.114988
Vancouver
Chen Z, Zhou H, Song J, Xu B, Wang C, He F, et al. A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.114988
BibTeX
@article{Chen2026,
author = {Chen, Zhiling and Zhou, Huiling and Song, Jie and Xu, Ben and Wang, Can and He, Fengchun and Zhang, Guisen and Zhuang, Tao},
title = {A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
doi = {10.1016/j.ejpb.2026.114988}
}
EUVIMED